Wells Fargo & Company Editas Medicine, Inc. Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 504,765 shares of EDIT stock, worth $610,765. This represents 0.0% of its overall portfolio holdings.

Number of Shares
504,765
Previous 182,877 176.01%
Holding current value
$610,765
Previous $854,000 101.52%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$3.39 - $5.96 $1.09 Million - $1.92 Million
321,888 Added 176.01%
504,765 $1.72 Million
Q2 2024

Aug 13, 2024
BUY
$4.67 - $7.28 $252,296 - $393,302
54,025 Added 41.93%
182,877 $854,000
Q1 2024

May 10, 2024
BUY
$7.03 - $11.07 $86,665 - $136,470
12,328 Added 10.58%
128,852 $956,000
Q4 2023

Feb 09, 2024
SELL
$6.25 - $11.11 $587,950 - $1.05 Million
-94,072 Reduced 44.67%
116,524 $1.18 Million
Q3 2023

Nov 13, 2023
SELL
$6.92 - $9.31 $39,596 - $53,271
-5,722 Reduced 2.65%
210,596 $1.64 Million
Q2 2023

Aug 15, 2023
BUY
$6.36 - $11.47 $7,517 - $13,557
1,182 Added 0.55%
216,318 $1.78 Million
Q1 2023

May 12, 2023
SELL
$7.03 - $11.53 $399,782 - $655,688
-56,868 Reduced 20.91%
215,136 $1.56 Million
Q4 2022

Feb 13, 2023
BUY
$8.32 - $13.21 $685,884 - $1.09 Million
82,438 Added 43.49%
272,004 $2.41 Million
Q3 2022

Nov 14, 2022
BUY
$12.16 - $19.42 $45,368 - $72,456
3,731 Added 2.01%
189,566 $2.32 Million
Q2 2022

Aug 12, 2022
BUY
$9.99 - $21.35 $182,207 - $389,402
18,239 Added 10.88%
185,835 $2.2 Million
Q1 2022

May 16, 2022
BUY
$14.08 - $27.63 $219,774 - $431,276
15,609 Added 10.27%
167,596 $3.19 Million
Q4 2021

Feb 14, 2022
SELL
$26.55 - $40.57 $1.82 Million - $2.78 Million
-68,436 Reduced 31.05%
151,987 $4.04 Million
Q3 2021

Nov 15, 2021
BUY
$39.27 - $72.94 $872,068 - $1.62 Million
22,207 Added 11.2%
220,423 $9.06 Million
Q2 2021

Aug 16, 2021
BUY
$31.29 - $56.64 $1.78 Million - $3.22 Million
56,850 Added 40.21%
198,216 $11.2 Million
Q1 2021

May 13, 2021
SELL
$39.71 - $90.58 $391,659 - $893,390
-9,863 Reduced 6.52%
141,366 $5.94 Million
Q4 2020

Feb 09, 2021
BUY
$27.07 - $84.35 $1.81 Million - $5.64 Million
66,908 Added 79.35%
151,229 $10.6 Million
Q3 2020

Nov 05, 2020
BUY
$28.06 - $37.16 $379,707 - $502,849
13,532 Added 19.12%
84,321 $2.37 Million
Q2 2020

Aug 13, 2020
BUY
$18.5 - $34.34 $253,949 - $471,385
13,727 Added 24.06%
70,789 $2.09 Million
Q1 2020

May 14, 2020
BUY
$14.88 - $32.78 $849,082 - $1.87 Million
57,062 New
57,062 $1.13 Million

Others Institutions Holding EDIT

# of Institutions
248
Shares Held
57M
Call Options Held
410K
Put Options Held
394K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $83.2M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email